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Background: Understanding the patterns of mammography use is essential to promote the participation in breast
cancer screening. Objectives: To describe the patterns of screening mammography use in Portugal. Methods: As
part of the fourth National Health Survey (2005/2006), 3045 women were evaluated in face-to-face interviews. The
previous use of mammography for screening was classified as never or ever, and the latter was further grouped
according to the time elapsed since the latest mammography. Having undergone the latest mammography >2
years before was considered underuse. We assessed the determinants of never having been screened by mam-
mography and, among those who had been tested, the determinants of mammography underuse, through age-
and education-adjusted odds ratios (ORs), with 95% confidence intervals (95% CIs). Results: Among women aged
45–49 and 50–69 years, 86.3% and 88.0%, respectively, underwent a screening mammography before, and most of
them were tested in the previous 2 years. The lowest risk of never having been screened was in Norte (OR=0.41,
95% CI: 0.21–0.80) and the highest in Ac¸ores (OR=4.04, 95% CI: 2.37–6.92), in comparison with Centro (the region
with organized screening for a longer time). Participants with <4 years of formal education were more likely to
have never been screened than the more educated (OR=4.27, 95% CI: 1.67–10.89). Women with private health
insurance (OR=0.16, 95% CI: 0.04–0.65), as well as those who had undergone cervical cytology screening before
(OR=0.50, 95% CI: 0.30–0.85), had a lower risk of underuse. Conclusions: This study provides useful information to
improve the allocation of resources to breast cancer screening.
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Introduction
Breast cancer accounted for 22.9% of all cancers and 13.7% of alldeaths in 2008.1 In Europe, the median decrease in breast cancer
mortality between 1989 and 2006 was 19%, which is partially attrib-
utable to a growing use of effective control measures such as early
detection by mammography.2,3
The European Council4 currently recommends the screening of
women aged 50–69 years through high-quality mammography
screening programmes. Organized mammographic screening is
considered an essential public health tool to reduce breast cancer
morbidity and mortality and to improve the quality of life of
patients,3,5 as well as to reduce inequalities in the access to early
detection. However, in many European countries, only opportunis-
tic screening is available or it coexists with organized programmes.6
Specifically in Portugal, organized breast cancer screening targeting
women aged 45–69 years was initially set up in the region of Centro
in 1990,7 having attained full geographical coverage in 2001.
Organized breast cancer screening was expanded to the remaining
of the country territory, though complete coverage was not achieved
yet.6,8
The extent to which women undergo mammography
screening depends on the existence of organized programmes and
on how they are functioning, the access to health-care services
and the knowledge and social representations about screening in
different population subgroups. Therefore, understanding the
patterns of mammographic screening use is essential to improve
the national health policy for cancer screening, both regarding
the promotion of the participation in the existing programmes
and for an effective transition from opportunistic to organized
screening.9,10
This study aimed to describe the use of mammography for
breast cancer screening by Portuguese women and to identify the
determinants of its non-use or underuse in this setting, using data
from the fourth National Health Survey (IV-NHS), conducted in
2005/2006.
Methods
Characteristics of the study sample and questionnaire
evaluation
The IV-NHS is a community-based cross-sectional study that
evaluated a sample of the Portuguese population, representative at
the national and regional (NUTS II—Territorial Nomenclature Units
for Statistical Purposes, level II) levels, obtained through complex
stratified and cluster sampling. People living in collective residential
institutions at the time of recruitment (e.g. hotels, hospitals and
military facilities) were not eligible. A sample of households was
defined, using data from the 2001 Population and Housing Census,
to be used as the sampling frame for household surveys conducted by
the National Institute of Statistics (INE). It included 1408 geograph-
ical units with at least 240 households each, selected systematically
within larger geographical strata, with a probability proportional to
the number of households in each unit. A random sample of the
households (secondary sampling units) was selected, and all
subjects living in these households were eligible. The sample size
was defined to ensure a homogeneous distribution of the participants
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by the seven NUTS II regions [Norte, Centro, Lisboa e Vale do Tejo
(LVT), Alentejo, Algarve, Regia˜o Auto´noma da Madeira and Regia˜o
Auto´noma dos Ac¸ores], and a coefficient of variation not exceeding
15% for subsamples with at least 5% of the population of any of the
regions.
Between February 2005 and January 2006, trained interviewers
evaluated 41 193 subjects, from 15 239 households, through
computer-assisted personal interviews. This corresponded to a par-
ticipation of 76% of the selected households. Interviews could not be
accomplished in 7% of dwellings that were not inhabited and in 5%
because of refusals to participate.
In addition to the socio-demographic characterization, the ques-
tionnaire covered 17 thematic areas. The questions referring to six of
these areas were applied only in one of the four trimesters, to ensure
that the average duration of the interviews did not exceed 75 min/
household. It included questions that were used to obtain informa-
tion from all participants (either directly or from a proxy
respondent), whereas some of them could not be answered by a
proxy.
The question referring to mammography testing was included in
the section that refers to ‘preventive care’, and was applied only to
women aged 20 years, between the 27th and 39th week of data
collection and had to be answered directly (no proxy responses were
allowed). Therefore, 3386 participants were eligible, and information
on mammography testing was available for 3373 women. The
present analyses were conducted among women aged above 29
years (n = 3045).
Women were inquired about the timing of their most recent
mammography, by asking ‘in which year did you have your most
recent mammography, that is, a chest radiography?’. This question
was preceded by an introduction referring to preventive care as
follows: ‘Now I would like to make you some brief questions
about people’s actions to prevent diseases’.
The IV-NHS database includes sampling weights to be used in
data analysis, for the estimates to be representative of the Portuguese
population. These were computed based on the inverse of the prob-
ability of selection of each sampling unit and further corrected for
non-responses and for the effective number of subjects evaluated.
Definition of the main variables and methods used
for statistical analysis
The previous use of mammography for screening was classified as
never or ever, and the latter group was further divided according to
the time elapsed since the date of the latest mammography testing:
up to 2 years, 3–5 years and > 5 years. The latter two categories were
classified as underuse.
Regarding age, the participants were grouped in five categories:
30–39, 40–44, 45–49, 50–69 and 70 years. These were defined
taking into account the European guidelines for breast cancer
screening (50–69 years)4 and the screening policy adopted in
Portugal (45–69 years).11
We computed the prevalences of screening mammography use in
different age-groups and used non-conditional logistic regression to
estimate the relation between socio-demographic characteristics,
access and use of health-care services and risk factors for chronic
diseases (smoking and overweight) and the use of mammography as
part of preventive care. We further assessed the determinants of
underuse among the women who had been tested before.
All analyses were conducted using the sampling weights, using
STATA version 11.2.
Results
Characteristics of the study sample
Nearly 50% of the population was aged 45–69 years and therefore
potentially eligible for breast cancer screening. Twenty-one percent
of the women had <4 years of schooling and just over one-tenth had
college education. Nearly 18% of the women had access to public
health care through a National Health Service subsystem, and 7.8%
had a private health insurance (table 1).
Mammography use for breast cancer screening
The overall proportion of women having undergone a screening
mammography at least once was 69.4% [95% confidence interval
(95% CI): 66.9–71.8]. The highest life prevalences were observed
among women aged 50–69 years (88.0%) and 45–49 years
(86.3%). In the age-group 40–44 years, the prevalence was slightly
lower (77.5%), and 41.9% of the younger women reported
a previous screening mammography. Most of the women aged
Table 1 Characteristics of the study sample (n=3045)
N Unweighted
(%)
Weighted
(%)
Region of residence (NUTS II)
Norte 458 15.0 33.2
Centro 488 16.0 17.2
LVT 408 13.4 36.5
Alentejo 446 14.7 5.2
Algarve 455 15.0 4.0
R.A. Ac¸ores 403 13.2 1.8
R.A. Madeira 387 12.7 2.1
Age (years)
30–39 519 17.0 22.1
40–44 310 10.2 10.5
45–49 329 10.8 9.6
50–69 1154 37.9 35.6
70 733 24.1 22.2
Education (years)
<4 688 22.6 20.7
4–5 1255 41.2 37.7
6–8 333 10.9 11.4
9–11 284 9.3 10.3
12a 228 7.5 9.7
>12b 257 8.5 10.2
Marital status
Single 278 9.1 9.2
Marriedc 2007 65.9 67.7
Divorced/separated 177 5.8 6.1
Widowed 583 19.2 17.0
Public health-care provider
NHS 2505 82.3 82.5
NHS and other subsystem 539 17.7 17.5
Private health insurance
No 2871 94.4 92.2
Yes 171 5.6 7.8
Doctor appointment (previous 3 months)
No appointment 1126 37.0 34.8
Yes (routine) 295 9.7 9.1
Yes (due to a medical condition) 1624 53.3 56.1
Cervical cytology screening
Never 1403 46.3 34.1
Yes (at least once) 1630 53.7 65.9
Smoking status
Never smoker 2593 85.2 82.1
Ex-smoker 187 6.1 8.1
Current smoker 265 8.7 9.8
BMI (kg/m2)
<18.5 44 1.5 1.4
18.5–24.9 1211 40.5 42.7
25.0–29.9 1109 37.1 36.0
30 623 20.9 19.9
R.A., Regia˜o Auto´noma (Autonomous Region); NHS, National
Health Service; BMI, body mass index.
a: Also includes participants with >12 years of non-university
education.
b: Includes all participants with university education.
c: Includes individuals who are legally married or cohabiting.
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30–69 years who had been screened reported the accomplishment of
their latest mammography test <3 years before, ranging from 72.3%
in the age-group 30–39 years to 90.2% among those aged 45–49
years. Among the older women (70 years), 55.7% reported
having undergone a screening mammography, mostly > 2 years
before (figure 1).
Determinants of having never undergone a
screening mammography
Women aged 45–69 years
Compared with women living in the Centro region (the region with
organized screening for a longer time), those from Algarve [odds
ratio (OR) = 2.59, 95% CI: 1.51–4.42] and Ac¸ores (OR = 4.04, 95%
CI: 2.37–6.92) were significantly more likely to have never
undergone a screening mammography, whereas the opposite was
observed for Norte (OR = 0.41, 95% CI: 0.21–0.80) and Alentejo
(OR = 0.47, 95% CI: 0.24–0.93) dwellers.
No statistically significant differences were observed between
women aged 45–49 years and those aged 50–69 years, or between
subjects with different levels of education, except for the higher risk
of never having undergone a mammography in the less educated
women (<4 vs. >12 years, OR = 4.27, 95% CI: 1.67–10.89).
Regarding marital status, married and divorced women were less
likely to have never undergone a screening mammography
(OR = 0.34, 95% CI: 0.16–0.76 and OR = 0.32, 95% CI: 0.10–0.99,
respectively). No statistically significant differences in the use of
mammography were observed between women according to the
access to different public health-care providers or the possibility of
benefiting from a private health insurance.
Women having had at least one routine doctor appointment in
the previous 3 months and those who underwent cervical cytology
screening before were 10 - and 20-fold less likely, respectively, of
having never undergone a screening mammography.
No significant differences were observed according to smoking
status, but obese women were less likely to having never
undergone a mammography as part of preventive care (OR = 0.52,
95% CI: 0.29–0.92) (table 2).
Women aged 70 years
The relation between the socio-demographic variables and not
having undergone a screening mammography was generally similar
to that observed among the age-group 45–69 years, despite some
differences in the point estimates and in the statistical significance of
the associations, owing to the smaller number of women aged >70
years that contributes to a lower precision of the estimates. The same
interpretation applies to the variables related to the use of
health-care services.
However, in contrast with that observed among the age-group 45–
69 years, smokers were less likely to have never undergone a
screening mammography, and the opposite was observed for
overweight/obese women, despite the associations were not statistic-
ally significant. For women with a body mass index of <18.5 kg/m2,
the OR was 6.68 (95% CI: 1.06–42.16) (table 2).
Women aged 30–44 years
In this age-group, when compared with the Centro dwellers, those
from Alentejo (OR = 1.61, 95% CI: 0.77–3.37), Algarve (OR = 1.65,
95% CI: 0.87–3.14), Ac¸ores (OR = 2.79, 95% CI: 1.46–5.34) and
Madeira (OR = 1.72, 95% CI: 0.83–3.55) were more likely to have
never undergone a screening mammography. As observed for the
other age-groups, women who had a recent doctor appointment and
those who underwent a cervical cytology screening were less likely to
have never undergone a mammography (table 2).
Determinants of screening mammography underuse
Women aged 45–69 years
No statistically significant associations were observed between the
socio-demographic characteristics and underuse of screening mam-
mography. However, the underuse tended to be more frequent in
the regions of Algarve and Ac¸ores and less frequent in LVT, Alentejo
and Madeira.
Women with a private health insurance were at a lower risk of
screening mammography underuse (OR = 0.16, 95% CI: 0.04–0.65),
Figure 1 Prevalence of mammography use for breast cancer screening in Portugal, according to the elapsed time since the latest testing
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as well as those who had a doctor appointment in the previous 3
months, either by routine (OR = 0.29, 95% CI: 0.10–0.86) or owing
to a medical condition (OR = 0.51, 95% CI: 0.30–0.87), and those
who underwent a cervical cytology screening before (OR = 0.50, 95%
CI: 0.30–0.85) (table 3).
Women aged 70 years
As observed among the women aged 45–69 years, a lower risk of
screening mammography underuse was observed for those living in
LVT (OR = 0.40, 95% CI: 0.17–0.94), Alentejo (OR = 0.42, 95% CI:
0.16-1.07) and Madeira (OR = 0.31, 95% CI: 0.11–0.83). A previous
cervical cytology screening was also negatively associated with
underuse in this age-group (OR = 0.53, 95% CI: 0.29–0.98).
Obesity was associated with a lower risk of screening mam-
mography underuse (OR = 0.25, 95% CI: 0.10–0.62) and
underweight with a higher risk (OR = 6.53, 95% CI: 0.94–45.24)
(table 3).
Women aged 30–44 years
In this age-group, married and divorced women were significantly
more likely to undergo screening mammographies less often than
the single. Women living in the Regia˜o Auto´noma da Madeira were
Table 2 Determinants of having never undergone a screening mammography
Women who never underwent a screening mammography
Women aged 30–44 Women aged 45–69 Women aged 70
% Adjusteda OR
(95% CI)
% Adjusteda OR
(95% CI)
% Adjusteda OR
(95% CI)
Region of residence (NUTS II)
Norte 43.8 0.89 (0.47–1.68) 8.6 0.41 (0.21–0.80) 43.2 0.55 (0.28–1.10)
Centro 46.2 1 (reference) 17.2 1 (reference) 55.6 1 (reference)
LVT 46.6 1.17 (0.62–2.19) 10.5 0.74 (0.39–1.42) 30.1 0.39 (0.19–0.78)
Alentejo 51.2 1.61 (0.77–3.37) 10.3 0.47 (0.24–0.93) 63.8 1.60 (0.84–3.05)
Algarve 53.7 1.65 (0.87–3.14) 27.8 2.59 (1.51–4.42) 70.5 2.21 (1.07–4.55)
R.A. Ac¸ores 65.8 2.79 (1.46–5.34) 38.8 4.04 (2.37–6.92) 71.4 2.30 (1.06–4.96)
R.A. Madeira 58.4 1.72 (0.83–3.55) 16.7 1.10 (0.60–2.04) 53.1 1.00 (0.51–1.97)
Age (years)
30–39 58.1 1 (reference) – – – –
40–44 22.5 0.12 (0.08–0.19) – – – –
45–49 – – 13.7 1.60 (0.92–2.80) – –
50–69 – – 12.0 1 (reference) – –
70 – – – – – –
Education (years)
<4 29.1 0.50 (0.09–2.79) 26.2 4.27 (1.67–10.89) 47.5 2.32 (0.50–10.69)
4–5 45.3 1.38 (0.67–2.85) 9.3 1.18 (0.49–2.84) 45.6 2.12 (0.46–9.84)
6–8 55.7 1.51 (0.77–2.93) 6.4 0.70 (0.21–2.29) 29.7 0.93 (0.10–8.59)
9–11 40.1 0.86 (0.41–1.82) 13.6 1.71 (0.50–5.89) 14.0 0.35 (0.05–2.30)
12b 48.0 1.01 (0.50–2.04) 6.1 0.64 (0.17–2.52) 34.1 1.21 (0.15–10.09)
>12c 43.1 1 (reference) 8.8 1 (reference) 29.8 1 (reference)
Marital status
Single 61.9 1 (reference) 27.2 1 (reference) 66.0 1 (reference)
Marriedd 44.1 0. 58 (0.29–1.15) 9.9 0.34 (0.16–0.76) 38.0 0.29 (0.11–0.73)
Divorced/separated 49.4 0.68 (0.27–1.73) 9.0 0.32 (0.10–0.99) 41.8 0.54 (0.11–2.72)
Widowed 50.8 1.90 (0.21–17.5) 18.9 0.57 (0.22–1.45) 46.5 0.32 (0.13–0.80)
Public health-care provider
NHS only 48.7 1 (reference) 13.9 1 (reference) 46.2 1 (reference)
NHS and other subsystem 38.1 1.15 (0.56–2.34) 6.4 0.52 (0.24–1.13) 23.9 0.53 (0.20–1.40)
Private health insurance
No 47.5 1 (reference) 12.9 1 (reference) 45.0 –
Yes 41.1 1.03 (0.52–2.04) 5.9 0.56 (0.18–1.80) –e –
Doctor appointment (previous 3 months)
No appointment 52.7 1 (reference) 24.5 1 (reference) 62.0 1 (reference)
Yes (routine) 39.1 0.39 (0.19–0.81) 3.0 0.11 (0.06–0.22) 34.7 0.23 (0.07–0.74)
Yes (due to a medical condition) 41.9 0.54 (0.33–0.89) 7.5 0.20 (0.12–0.32) 38.7 0.35 (0.21–0.58)
Cervical cytology screening
Never 77.3 1 (reference) 35.0 1 (reference) 59.6 1 (reference)
Yes (at least once) 40.3 0.13 (0.07–0.26) 2.8 0.05 (0.03–0.10) 13.3 0.11 (0.05–0.22)
Smoking status
Never smoker 50.4 1 (reference) 12.6 1 (reference) 45.2 1 (reference)
Ex-smoker 40.0 0.78 (0.35–1.71) 9.0 0.98 (0.34–2.82) 12.2 0.44 (0.10–2.02)
Current smoker 39.2 0.74 (0.43–1.26) 13.4 1.35 (0.45–4.07) 5.2 0.12 (0.01–1.75)
BMI (kg/m2)
<18.5 44.9 0.70 (0.16–2.98) 16.9 1.34 (0.23–7.97) 80.2 6.68 (1.06–42.16)
18.5–24.9 52.3 1 (reference) 15.4 1 (reference) 39.8 1 (reference)
25.0–29.9 33.3 0.51 (0.31–0.83) 10.7 0.59 (0.34–1.01) 45.3 1.43 (0.83–2.46)
30 46.8 0.81 (0.43–1.54) 9.9 0.52 (0.29–0.92) 41.7 1.23 (0.64–2.35)
a: Age- and education-adjusted.
b: Also includes participants with >12 years of non-university education.
c: Includes all participants with university education.
d: Includes individuals who are legally married or cohabiting.
e: There were no observations in this group.
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less likely to have undergone a screening mammography >2 years
before (OR = 0.21, 95% CI: 0.05–0.82), as well as those covered by a
National Health Service subsystem (OR = 0.30, 95% CI: 0.10–0.85)
(table 3).
Discussion
Nine of 10 women at an eligible age for breast cancer screening have
undergone a mammography before, as part of preventive care.
However, nearly one-third of the younger women, for whom
screening is not recommended, also reported a previous use of
mammography screening. Most women aged 45–69 years
underwent their latest mammography testing in the previous
2 years. Both the use and the underuse of this type of preventive
care among eligible women varied widely across the country and
with socio-demographic characteristics and access and use of
health-care services.
These results are largely dependent on the local specificities of the
Portuguese health system, as well as the demographic and epidemio-
logical characteristics of the country, which limits the
Table 3 Determinants of screening mammography underuse (more recent mammography performed >2 years before) among women
reporting having undergone a screening mammography before
Women who underwent the more recent mammography >2 years beforea
Women aged 30–44 Women aged 45–69 Women aged 70
% Adjustedb OR
(95% CI)
% Adjustedb OR
(95% CI)
% Adjustedb OR
(95% CI)
Region of residence (NUTS II)
Norte 28.7 1.14 (0.49–2.67) 14.0 0.77 (0.40–1.46) 59.4 0.87 (0.38–1.98)
Centro 25.5 1 (reference) 17.0 1 (reference) 64.4 1 (reference)
LVT 19.8 0.76 (0.32–1.83) 10.6 0.56 (0.27–1.15) 46.9 0.40 (0.17–0.94)
Alentejo 34.0 1.56 (0.63–3.89) 12.6 0.59 (0.30–1.16) 42.2 0.42 (0.16–1.07)
Algarve 26.3 1.14 (0.47–2.75) 24.9 1.70 (0.87–3.32) 57.0 0.76 (0.29–1.98)
R.A. Ac¸ores 24.7 0.92 (0.36–2.34) 25.7 1.76 (0.89–3.49) 54.9 0.83 (0.27–2.53)
R.A. Madeira 8.7 0.21 (0.05–0.82) 8.3 0.48 (0.21–1.09) 32.5 0.31 (0.11–0.83)
Age (years)
30–39 29.7 1 (reference) – – –
40–44 21.4 0.70 (0.36–1.37) – – – –
45–49 – – 9.8 0.72 (0.39–1.32) – –
50–69 – – 14.5 1 (reference) – –
70 – – – 53.5 –
Education (years)
<4 50.5 3.73 (0.52–26.74) 21.0 1.85 (0.65–5.30) 50.9 2.28 (0.28–18.81)
4–5 24.4 1.21 (0.41–3.57) 12.0 0.97 (0.37–2.56) 57.5 2.98 (0.35–25.37)
6–8 29.4 1.50 (0.50–4.51) 6.9 0.56 (0.14–2.19) 52.2 2.57 (0.18–36.08)
9–11 22.2 1.02 (0.32–3.30) 20.7 1.93 (0.59–6.29) 60.4 2.41 (0.21–27.83)
12c 22.7 1.02 (0.32–3.27) 9.7 0.84 (0.23–3.02) 49.2 1.60 (0.09–27.54)
>12d 21.5 1 (reference) 11.7 1 (reference) 27.7 1 (reference)
Marital status
Single 13.7 1 (reference) 13.2 1 (reference) 52.5 1 (reference)
Marriede 25.5 2.32 (0.69–7.76) 11.7 1.06 (0.38–2.97) 46.4 0.56 (0.12–2.55)
Divorced/separated 31.1 3.68 (0.76–17.73) 20.8 2.13 (0.59–7.65) 37.3 0.52 (0.05–5.92)
Widowed 5.5 0.57 (0.03–12.31) 21.3 1.66 (0.53–5.21) 60.8 0.69 (0.15–3.18)
Public health-care provider
NHS only 28.9 1 (reference) 14.3 1 (reference) 53.4 1 (reference)
NHS and other subsystem 10.5 0.30 (0.10–0.85) 10.8 0.71 (0.36–1.40) 54.1 1.12 (0.38–3.34)
Private health Insurance
No 26.9 1 (reference) 14.4 1 (reference) 53.4 1 (reference)
Yes 12.3 0.42 (0.15–1.19) 2.8 0.16 (0.04–0.65) 54.4 1.55 (0.16–14.9)
Doctor appointment (previous 3 months)
No appointment 27.4 1 (reference) 18.2 1 (reference) 63.8 1 (reference)
Yes (routine) 20.5 0.64 (0.22–1.89) 6.6 0.29 (0.10–0.86) 69.4 0.98 (0.26–3.66)
Yes (due to a medical condition) 23.6 0.77 (0.39–1.53) 12.6 0.51 (0.30–0.87) 49.8 0.58 (0.26–1.31)
Cervical cytology screening
Never 41.2 1 (reference) 23.1 1 (reference) 63.5 1 (reference)
Yes (at least once) 23.5 0.47 (0.19–1.16) 10.8 0.50 (0.30–0.85) 44.0 0.53 (0.29–0.98)
Smoking status
Never smoker 24.7 1 (reference) 12.8 1 (reference) 54.1 1 (reference)
Ex-smoker 23.8 1.08 (0.35–3.36) 17.1 1.75 (0.57–5.33) 43.6 1.08 (0.15–7.60)
Current smoker 25.3 1.15 (0.54–2.45) 18.6 2.02 (0.64–6.42) –f –
BMI (kg/m2)
<18.5 57.0 3.44 (0.11–106.84) 12.1 0.70 (0.10–4.89) 90.3 6.53 (0.94–45.24)
18.5–24.9 24.0 1 (reference) 12.8 1 (reference) 66.1 1 (reference)
25.0–29.9 27.7 1.26 (0.61–2.61) 12.9 0.94 (0.53–1.68) 52.5 0.51 (0.26–1.04)
30 17.2 0.57 (0.18–1.79) 15.6 1.31 (0.69–2.49) 28.3 0.25 (0.10–0.62)
a: The present analysis includes only women who underwent a screening mammography before.
b: Age- and education-adjusted.
c: Also includes participants with >12 years of non-university education.
d: Includes all participants with university education.
e: Includes individuals who are legally married or cohabiting.
f: There were no observations in this group.
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generalizability of the findings to other settings. Nevertheless, this
study evaluated a large representative sample of Portuguese women
and provides information for understanding the relation between
the national health policy for cancer screening and the use of
screening mammography. Other limitations also need to be
acknowledged for a proper interpretation of the findings.
The data for the present analysis were self-reported, and therefore,
it is not possible to ensure that all the reports referred to screening
mammographies. The potential overestimation of mammography
use for screening purposes due to the reporting of diagnostic
mammograms is expectedly minor and may have been further
minimized, as the questions on this topic were part of a section
referring specifically to preventive care. However, the question that
assessed mammography use referred to this examination using the
terms ‘mamografia’ (mammography) and ‘radiografia ao peito’
(chest radiography). In the Portuguese language, the latter may be
interpreted as breast or chest radiography, which may have
contributed to the high proportion of women aged 30–39 years
who reported having undergone a mammography, despite
screening not being recommended at this age. The overestimation
of the use of mammography testing should have been much lower
among the women aged >45 years, eligible for screening, and the
interpretation of the prevalence estimates in this age-group is not
expected to be compromised by the lack of specificity of the
instrument of data collection. We may use our results to support
the validity of these assumptions. For example, the region Centro is
covered by organized screening, for women aged 45–69 years, since
the 1990s,6,12 and the participation rate in the most recent years was
69%.7 This is compatible with our estimates of the life prevalence of
screening mammography (82.8%) and the proportion of women
having undergone it in the previous 2 years (83.0%). In Algarve,
our estimates for mammography testing during life and for the
proportion of screened women having undergone a mammography
in the previous 2 years are 72.2% and 75.1%, respectively. In this
region, the organized screening started only in 2005, and only 58% of
the women invited in 2008–10 participated.13 In Norte, only 12.5% of
the eligible population was covered in 2009, with a participation rate
of 60.6%,14 and the high life prevalence of mammography use
estimated in our study may be interpreted as the result of a quanti-
tatively important overestimation. However, this is a heterogeneous
region that includes the large urban area of Porto, where access to
opportunistic screening is expectedly high,15 and may result in a large
proportion of the population being screened, even in the absence of
organized screening. According to the Regional Health
Administration of Norte (ARS Norte), in 2009, 54% of the women,
with eligible age for screening, using the primary health-care centres
had undergone a mammography.14 This is further supported by the
available data on the cervical cancer screening obtained in Porto,
where no organized programme was available, that showed a life
prevalence of cervical cytology use >90%, and a large proportion of
women being tested annually.16
In the Regia˜o Auto´noma da Madeira, breast cancer screening
started in 1999, and in 2004–05 (third round of screening), the
participation rate was 60%. In the Alentejo region, organized
screening started in 2002, and by 2006, not all districts were
covered. In the region of Lisboa e Vale do Tejo, organized breast
screening started to operate in 2002, and by 2006, the coverage was
still low. In the region of Algarve, organized screening started only in
2005,17 and in the Regia˜o Auto´noma dos Ac¸ores, it started in 2009.
This shows that the existence of a screening programme does not
necessarily correspond to a higher proportion of women undergoing
screening mammography, as opportunistic screening may be
frequent and the programmes did not reach all the eligible
women, owing to insufficient coverage and/or participation.
To disentangle the contribution of opportunistic screening and
screening programmes for the overall mammography use, we would
need to distinguish between examinations performed opportunistic-
ally and those conducted within organized screening. Unfortunately,
no such information is available, and thus, no further discussion of
this issue is possible.
The results show a less frequent utilization of screening mammog-
raphy by women aged >70 years than by those aged 45–69 years.
This reflects a higher proportion of older women never having
undergone a mammography and recall bias,18 which is more likely
to occur as age increases.
Our results are in accordance with previous studies that showed
significant associations between mammography use and factors
related with education,19–22 access to health-care services20,22–24
and preventive care.23,25,26 The less frequent reporting of mammog-
raphy use by the less educated women could be mediated by factors
such as lower access to health information,27,28 lower adherence to
organized screening21 or recall bias.19 The regular contact with
primary health-care physicians has been positively associated with
mammography screening24,29 and within the recommended time
frames.26 Moreover, having private health insurance and having
undergone a cervical cytology before was associated with a lower
risk of non-use and underuse of breast cancer screening. Although
women who engage in preventive activities are more likely to
undergo a screening programme,25 our results confirmed that a po-
tentially easier access to health care, through public subsystems or
private health insurance, is associated with a lower risk of not being
screened. Recent interaction with the usual health-care provider
increased the odds of having a mammography in the previous 2
years.
Previous studies have associated smoking with lower frequency of
screening,22,26 whereas overweight/obesity has been associated with
lower,30 equal20,31 or higher32 risk of screening. We did not observe
differences according to smoking status, but obese women were less
likely to have never undergone a mammography, which is relevant
because obesity is a risk factor for breast cancer.33
Although opportunistic screening may attract more subjects
having higher education levels,34 and organized programmes are
expected to cover proportionally more women of more disadvan-
taged social classes,35 in our study, there were no significant differ-
ences between the regions with full coverage by organized screening
(Centro and Autonomous Region of Madeira) and those with only
partial or no coverage (data not shown). This may be explained by
the fact that the participation in screening in Centro and in the
Autonomous Region of Madeira was <70%, that most regions had
already a partial coverage of screening in 2005–06 and/or that the life
prevalence of mammography use was high in most settings.
In conclusion, both the risk of never having undergone a mam-
mography and its underuse varied widely across the country and
with socio-demographic characteristics and health-care utilization,
depicting inequalities in the use of mammography screening. This
study provides useful information to improve the allocation of
resources to breast cancer screening.
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Key points
 Most women with an eligible age for breast cancer screening
underwent a mammography before, and most of them were
tested in the previous 2 years.
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 Less educated and single women were less likely to have not
been screened for breast cancer before.
 Women with private health insurance and those who had
undergone a cervical cytology before were at lower risk of
breast cancer screening underuse.
 This study provides useful information to improve the
allocation of resources to breast cancer screening.
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